Cohort Follow-up: Progression and Consequences of Chronic Kidney Disease.

Completed

• Conditions: Renal Function Disorder; Chronic Renal Diseases

• Registration Number: NCT04070885
• Lead Sponsor: University Hospital, Bordeaux

Brief Summary

This study aims to conduct a prospective collection of clinical and para-clinical data in patients with Chronic Renal Diseases to identify disease progression factors, markers of renal function, and the pathophysiology of Chronic Renal Diseases complications.

Detailed Description

Chronic Renal Diseases have a growing incidence and prevalence in France, with significant consequences in terms of morbidity and mortality, especially cardiovascular, and Public Health.

It is necessary to know better:

* the mechanisms leading to the progression of the Chronic Renal Diseases

* markers to quantify renal function and progression of the Chronic Renal Diseases

* the pathophysiology of Chronic Renal Diseases complications, cardiovascular, nutritional, or mineral metabolism in particular.

This study aims to conduct a prospective collection of clinical and para-clinical data in patients with Chronic Renal Diseases to identify disease progression factors, markers of renal function, and the pathophysiology of Chronic Renal Diseases complications.

Study Timeline

• Study Start: 2011-01-05
• Primary Completion: 2015-03-20
• Study Completion: 2015-03-20
• Status Verified: 2019-08
• Study First Submitted: 2019-08-22
• Study First Submitted QC: 2019-08-26
• Last Update Submitted: 2019-08-26
• Study First Posted: 2019-08-28
• Last Update Posted: 2019-08-28

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 210

Inclusion Criteria

• Patients with Chronic Renal Disease, stage 2 to 5, non-dialysis patients over the age of 18,
• followed in the Nephrology Department of the Bordeaux University Hospital
• agreeing to participate in NephroTest
• affiliated with social security.

Exclusion Criteria

• Patients under 18 years
• Patients with acute or rapidly progressive renal failure
• Patients with severe comorbidities or comorbidities that are life-threatening in the short term (<1 year)
• Patients who did not give their written consent to be included in the study
• Major incapacitated patients and psychiatric patients admitted to hospital

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Estimated Glomerular Filtration Rate measurement	At 2 year after inclusion	by isotope technique
Measured Glomerular Filtration Rate	At 2 years after inclusion	by isotope technique